Together, we rise to the challenges of today. We share knowledge and identify real solutions for tomorrow. And with dedicated clinicians and partners like you, we are advancing heart care worldwide, ...

Imagine this: the selection committee for the Nobel Prize in Physiology or Medicine is set to honor an advancement in cardiology in 2025. The question is not whether cardiology deserves it – but ...

In this week’s View, Dr. Eagle looks at what adult cardiologists should know about congenital heart disease patients. He then discusses sudden cardiac arrest and death in competitive and recreational ...

The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, ...

In this week’s View, Dr. Eagle looks at the 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. He then discusses sex differences in ...

The first successful percutaneous transluminal coronary angioplasty was performed by Andreas Gruentzig, MD, in September 1977. Despite careful lesion selection, the initial equipment consisted of ...

The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

The American Heart Association (AHA) 2024 Scientific Sessions in Chicago provided a platform for sharing the latest advancements in interventional cardiology. Here we delve into some of the most ...

The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute ...

Our records indicate that the Ovid subscription has been in our system for over a year. Please contact your administrator or librarian to make sure the institutional subscription to Cardiosource Plus ...

Cathleen Biga, MSN, FACC, is President and CEO of Cardiovascular Management of Illinois, a cardiology physician practice management company. She has worked with more than 100 cardiovascular providers ...